Personalized Medicine Talking Points
Lung Cancer Awareness Month
TOPIC: Personalized Medicine –Laymen’s Summary and Main Message
Personalized Medicine - Laymen's Summary and Main Message
March 2017 Newsletter
The management of patients with thoracic cancers presents both unique opportunities as well as challenges.
DENVER, Colo. – If cancer patients are to receive optimal treatment, clinicians must have an accurate histologic classification of the tumor and know its genetic characteristics, said William D. Travis, M.D., attending thoracic pathologist, Department of Pathology, at Memorial Sloan Kettering Cancer Center in New York City. Dr. Travis made his remarks today at the 16th World Conference on Lung Cancer (WCLC) hosted by the International Association of the Study of Lung Cancer (IASLC).